CD4 and neoplasm: Knock out of COX‐2 expression in tumor cells deeply impacts on TME composition, resulting in increased recruitment of potent antitumor effectors, such as effector NK cells, memory CD8+, and CD4+ T cells, and a concomitant reduction in nonclassical monocytes, followed by a shift of M2‐like toward M1‐like macrophages.